FDA drug center chief Janet Woodcock warned her staff on Monday (Jan. 28) that progress on rules and guidances might be slower than usual as the agency recovers from a month-long partial government shutdown that left 41 percent of its staff furloughed. “A first order of business for [the drug center] will be to pick up the pieces and prioritize the work that has piled up,” Woodcock said. “We can expect other parts of the agency and government to be...